Owen McCarty/LinkedIn
May 17, 2026, 11:04
Owen McCarty: Few Insights and Implications from Recent Clinical Trials of FXI Inhibitors
Owen McCarty, Professor and Chair at Oregon Health and Science University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Advances in Therapy, adding:
”We summarized a few insights and implications from recent clinical trials of coagulation FXI inhibitors.”
Title: Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent Trials
Authors: Rosemary B. Falama, Lisa R. Matsumoto, Marie E. Piatski, Lukas Seifer, Aditya Malhotra, Owen J. T. McCarty, Joseph J. Shatzel

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA